Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

17 Jun 2026 - 19 Jun 2026
08 Jul 2026 - 10 Jul 2026

Emerging Blood-Borne Bacteria Found in Blood Donors

By LabMedica International staff writers
Posted on 04 Apr 2016
Bartonella species cause chronic and intermittent intra-erythrocytic bacteremia and infect endothelial cells of both incidental and natural reservoir hosts. More...
The establishment of chronic, stealth infection is achieved by evasion of innate immune responses.

In humans, Bartonella species have been detected from sick patients presented with diverse disease manifestations, including cat scratch disease, trench fever, bacillary angiomatosis, endocarditis, polyarthritis, or granulomatous inflammatory disease.

An international team of scientists, led by those at the Western University of Health Sciences, Pomona, CA, USA), collected blood from 500 apparently healthy Brazilian voluntary blood donors in a cross sectional study. Bartonella species infection from the bloodstream was detected based on enrichment blood culture in a liquid growth medium (Bartonella alpha-Proteobacteria growth medium-BAPGM), coupled with isolation in solid medium. Bartonella-specific DNA was amplified by polymerase chain reaction (PCR), followed by DNA sequencing to confirm species identification. Of the ten Bartonella species that are believed to produce infection in humans, the most commonly encountered are B. henselae, B. quintana, and B. bacilliformis. The latter causes Oroya fever and Verruga peruana.

Bartonella species bloodstream infection was detected in 16/500 blood donors (3.2%). DNA amplification and sequencing identified B. henselae in 15 blood donors (3%) and B. clarridgeiae in one donor (0.2%). B. henselae bacteremia was also confirmed in six donors by bacterial isolation. Adjusted odds ratio indicated that subjects with cat contact, or past history of tick bite, were approximately three to four times more likely to have a Bartonella species infection than donors without cat contact or lack of history of tick bite.

The authors concluded that the risk factors of cat contact or tick bites should be considered during donor screening, as bacteremia by these Bartonella species may not be detected by traditional laboratory screening methods, and it may be transmitted by blood transfusion. The study was published on March 21, 2016, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Western University of Health Sciences



Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Clinical Informatics Platform
CLARION™
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.